Comera Life Sciences Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Comera Life Sciences prevailing Real Value cannot be determined due to lack of data. The current price of Comera Life Sciences is $0.0. Our model approximates the value of Comera Life Sciences from analyzing the firm fundamentals such as Operating Margin of (15.82) %, shares outstanding of 30.74 M, and Return On Equity of -16.29 as well as examining its technical indicators and probability of bankruptcy.
Comera Life Total Value Analysis
Comera Life Sciences is currently projected to have valuation of 9.96 M with market capitalization of 6.85 M, debt of 775.05 K, and cash on hands of 4.94 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Comera Life fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
9.96 M | 6.85 M | 775.05 K | 4.94 M |
Comera Life Investor Information
About 51.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.22. Comera Life Sciences had not issued any dividends in recent years. The entity had 1:1 split on the 20th of May 2022. Based on the measurements of operating efficiency obtained from Comera Life's historical financial statements, Comera Life Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Comera Life Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Comera Life has an asset utilization ratio of 16.99 percent. This suggests that the Company is making $0.17 for each dollar of assets. An increasing asset utilization means that Comera Life Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Comera Life Ownership Allocation
Comera Life holds a total of 30.74 Million outstanding shares. Comera Life Sciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Comera Life Profitability Analysis
The company reported the previous year's revenue of 633.1 K. Net Loss for the year was (18 M) with profit before overhead, payroll, taxes, and interest of 422.71 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Comera Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Comera Life and how it compares across the competition.
Comera Life Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 10.5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Comera Pink Sheet
If you are still planning to invest in Comera Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Comera Life's history and understand the potential risks before investing.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |